Clinical trials sponsored by Shanghai Zhongshan Hospital
21
Recruiting trials
15
Conditions studied
Phase breakdown
Early Phase 1 1Phase 1 1Phase 2 5Phase 3 1Phase 4 2Not applicable 12
Conditions studied
Recruiting trials led by Shanghai Zhongshan Hospital
- A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome
- A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data
- ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management
- An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer
- Asiaticoside for Treating Overweight/Obesity
- Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
- Construction of a Portal Hypertension Biobank
- Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease
- Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome
- Effect of Low Valine Diet on Body Weight and Metabolic Parameters
- Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community
- Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
- Efficacy of Mazdutide for Treating PCOS
- Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS
- Evaluation of the Efficacy and Safety of Fecal Microbiota Transplantation for Constipation in Parkinson's Disease
- FreeFlow Percutaneous Atrial Septal Shunt for IPAH
- Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension
- Indicators Affecting PVT Recanalization
- NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer
- The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial
- Treatment Outcomes for Portal Hypertension Esophageal and Gastric Varices
Common questions
How many trials is Shanghai Zhongshan Hospital recruiting for?
Shanghai Zhongshan Hospital is the lead sponsor of 21 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.